- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
AstraZeneca Pharma India Limited — Updates, 24-08-2026: General Updates
24-08-2026 | 08:55 pm
24-08-2026 | 08:55 pm
AstraZeneca Pharma India independently received an ESG rating of 57 from Crisil ESG Ratings. This external assessment, based on public data, highlights the company's environmental, social, and governance profile.
No comments yet. Be the first to comment!